Tc Biopharm [Holdings] Plc ADR (TCBP)

Jan 15, 2025, 8:30 AM EST - 2 days ago

TCBP Announces H5N1 Proof of Concept Studies Intention

Jan 13, 2025, 8:45 AM EST - 4 days ago

TCBP to Present at Sequire Investor Summit 2025

Jan 6, 2025, 1:30 PM EST - 11 days ago

TCBP Trading Continues Unabated on Nasdaq Stock Exchange

Dec 31, 2024, 10:15 AM EST - 17 days ago

TCBP Provides Update on Acquisition Strategy and Current Targets

Dec 30, 2024, 10:30 AM EST - 18 days ago

TCBP Issues 25% Stock Dividend

Dec 20, 2024, 8:30 AM EST - 4 weeks ago

TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients

Dec 18, 2024, 8:30 AM EST - 4 weeks ago

TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend

Dec 18, 2024, 8:00 AM EST - 4 weeks ago

EXCLUSIVE: Penny Stock TC BioPharm Proposes Special Stock Dividend

Dec 11, 2024, 7:00 AM EST - 5 weeks ago

TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy

CDNA

Dec 4, 2024, 8:30 AM EST - 6 weeks ago

TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical Trial

Nov 12, 2024, 9:30 AM EST - 2 months ago

TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant

Oct 30, 2024, 8:30 AM EDT - 2 months ago

TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements

Oct 25, 2024, 9:45 AM EDT - 3 months ago

TCBP Responds to False Social Media Claim

Oct 22, 2024, 8:30 AM EDT - 3 months ago

TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic

Oct 3, 2024, 8:30 AM EDT - 3 months ago

TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening

Sep 25, 2024, 8:30 AM EDT - 4 months ago

TCBP Announces Site Opening of Guys and St. Thomas Hospital

Sep 24, 2024, 8:45 AM EDT - 4 months ago

TCBP to Present at the 2024 ThinkEquity Conference in NYC

Sep 12, 2024, 8:30 AM EDT - 4 months ago

TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial

Sep 9, 2024, 8:30 AM EDT - 4 months ago

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox

Sep 5, 2024, 8:30 AM EDT - 4 months ago

TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 3, 2024, 8:30 AM EDT - 4 months ago

TCBP Announces Dosing of 5 New Patients in ACHIEVE

Aug 28, 2024, 5:15 PM EDT - 5 months ago

TC BioPharm Announces Closing of Upsized $6.0 Million Public Offering

Aug 28, 2024, 1:50 PM EDT - 5 months ago

TC BioPharm Announces Grant of European Patent Covering Use of Modified Gamma Delta Cells for the Treatment of Cancer and Viral Indications

Aug 15, 2024, 1:00 PM EDT - 5 months ago

TC BioPharm Regains Compliance with Nasdaq Listing Rule 5550(b)

Aug 15, 2024, 11:30 AM EDT - 5 months ago

TC BioPharm Announces Closing of $2.0 Million Public Offering

Aug 13, 2024, 4:30 PM EDT - 5 months ago

TC BioPharm Announces Pricing of $2.0 Registered Direct Offering

Jul 31, 2024, 8:00 AM EDT - 6 months ago

TCBP Announces Plan to Implement ADS Ratio Change

Jul 22, 2024, 8:00 AM EDT - 6 months ago

TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia

May 15, 2024, 8:30 AM EDT - 8 months ago

TCBP Announces Launch of Compassionate Use Program for TCB008

May 6, 2024, 1:01 PM EDT - 9 months ago

TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds

May 6, 2024, 8:30 AM EDT - 9 months ago

TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies

Apr 4, 2024, 8:32 AM EDT - 10 months ago

TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies

Apr 2, 2024, 8:30 AM EDT - 10 months ago

TCBP Increasing Treatment Capacity with Expanded Manufacturing Process

Mar 19, 2024, 8:30 AM EDT - 10 months ago

TCBP Adjourns General Meeting Until a Later Date

Mar 18, 2024, 8:30 AM EDT - 10 months ago

TCBP Announces Exercise of Series D Warrants For Cash

Mar 1, 2024, 8:30 AM EST - 11 months ago

Bryan Kobel, CEO of TCBP, Appears on Nationally Syndicated "The Big Biz Show"

Feb 27, 2024, 8:30 AM EST - 11 months ago

TCBP Announces Shareholder Update Call on March 5th 2024

Feb 22, 2024, 9:32 AM EST - 11 months ago

TCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK Trial

Feb 15, 2024, 8:30 AM EST - 1 year ago

TC BioPharm Management to Participate at Upcoming 7th CAR-TCR Summit Europe

Feb 14, 2024, 8:30 AM EST - 1 year ago

TCBP Provides Shareholder Update and Highlights Upcoming Milestones

Jan 29, 2024, 8:30 AM EST - 1 year ago

TC BioPharm Chief Executive Officer, Bryan Kobel Featured on 'The Big Biz Show'

Jan 18, 2024, 8:30 AM EST - 1 year ago

TC BioPharm to Present at the Sequire Investor Summit

Jan 4, 2024, 8:30 AM EST - 1 year ago

TC BioPharm Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jan 3, 2024, 8:30 AM EST - 1 year ago

TC BioPharm Announces Additional Cost Reduction Steps to Improve Financial Standing and Streamline Efficiencies

Dec 22, 2023, 8:30 AM EST - 1 year ago

TC BioPharm Announces Closing of $3.5 Million Public Offering

Dec 19, 2023, 8:00 AM EST - 1 year ago

TC BioPharm Announces Pricing of $3.5 Million Public Offering

Dec 18, 2023, 11:15 AM EST - 1 year ago

TC BioPharm Announces Formation of Commercial Development Division, Led by Industry Veteran, Dr. Lauren Bor Ph.D

Dec 13, 2023, 6:30 AM EST - 1 year ago

TC BioPharm Announces Plan to Implement ADS Ratio Change

Nov 27, 2023, 8:45 AM EST - 1 year ago

TC BioPharm Announces FDA Clearance of Phase 1B IND for TCB-008 in Acute Myeloid Leukemia

Nov 14, 2023, 10:00 AM EST - 1 year ago

TC BioPharm Announces Successful Completion of Safety Cohort and Positive DSMB Results